Back
ESC Premium Access

Treatment decisions based on individual estimated lifetime benefit versus individual estimated 10-year absolute risk reduction: a cost-effectiveness analyses with PCSK9 inhibition.

Session: Best Posters 5 - Best Posters in preventive cardiology
Topic: Epidemiology
Speaker: Mr G. Berkelmans (Utrecht, NL)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Mr Gijs Berkelmans

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

4 more presentations in this session

Discussant: Best Posters in preventive cardiology

Access
Thumbnail

Chronotype and diabetes in middle-aged and elderly people: Importance of mismatch between chronotype and actual lifestyle

Speaker: Doctor N. Sasaki (Hiroshima, JP)

Access
Abstract
Slides
Thumbnail

Cardiometabolic risk factors in hypertensive children and adolescents: The PEP Family Heart Study

Speaker: Professor P. Schwandt (Munich, DE)

Access
Abstract
Slides
Thumbnail

Favourable long-term effects of a cardiovascular prevention program in primary health care in Sweden in men, and women on first cardiovascular events, cardiovascular mortality, and all-cause mortality

Speaker: Doctor G. Journath (Stockholm, SE)

Access
Abstract
Thumbnail

Access the full session

Best Posters 5 - Best Posters in preventive cardiology

Speakers: Mr G. Berkelmans, Doctor N. Sasaki, Professor P. Schwandt, Doctor G. Journath
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb